Efficacy of Grape seed in management of hypertensio
Phase 1
- Conditions
- Nutritional, Metabolic, Endocrine
- Registration Number
- PACTR202310608817705
- Lead Sponsor
- African ai Japan project JICA JKUAT PAUSTI
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
All patients aged 18-80 years with hypertension and no other complication
Those who consent to participate
Exclusion Criteria
Those patients with hypertension aged 18-80 years with complications like renal failure and cardiovascular disorder Those eligible but do not consent to participate
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Mean change percentage systolic and diastolic blood pressure of the participants post-intervention
- Secondary Outcome Measures
Name Time Method Changes in mean fasting HbA1c of the participants post-intervention;a.Change in mean body mass index (BMI) of the participant post-intervention<br>b.Change in mean waist circumference of the participants post-intervention<br>c.Change in mean waist-hip ratio of the participant post-intervention <br>d.Change in mean weight for height ratio post-intervention<br>e.Change in mean body fat and visceral fat post-intervention<br>;a.Change in mean triglyceride levels of the participants post-intervention<br>b.Change in mean high-density lipoprotein cholesterol(HDL-C) levels of the participants post-intervention<br>c. Change in mean low-density lipoprotein cholesterol (LDL-C) levels post-intervention <br>d.Change in mean total cholesterol levels of the participants post-intervention<br>;a.Mean change in c-reactive protein post-intervention <br><br>;a.Mean change in sodium, potassium, and chloride post-intervention<br>b.Mean change in urea, creatinine, and albumin post-intervention<br>